Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Disclaimer: This document is...
ZURA is registering massive massive volume based on weekly data. Volume net buys have increase two-folds from its average numbers, from 2.3M average volume to 5.7M last trading day. A huge hint of things to come for this stock after a FWB:80M financing for its Phase 2 clinical trial for ZB-106 in systemic sclerosis (SSc), followed by a Phase 2 clinical trial in...